Company: ENTXW
Filing Date: 2025-05-30
Form Type: S-3
Source: 0001178913-25-002025
Chunk: 63

Company: Entera Bio Ltd.
Filing Date: 2025-05-30
Form: S-3
Chunk 63
---
 registration fee*             |     | $ |  1,553.47 | * |
| FINRA filing fee                  |     | $ |  2,022.02 |   |
| Printing and engraving expenses** |     | $ |     5,000 |   |
| Legal fees and expenses**         |     | $ |    53,000 |   |
| Accounting fees and expenses**    |     | $ |    15,000 |   |
| Miscellaneous**                   |     | $ |    15,000 |   |
| Total*                            |     | $ | 91,575.49 |   |

| * | Pursuant to Rule 415(a)(6) under the Securities Act, the securities registered pursuant to this registration statement include unsold securities previously registered on the Company’s Registration Statement on Form S-3 (File No.            
 333-265286) filed on May 27, 2022, and declared effective on June 9, 2022 (the “Prior S-3 Registration Statement”), including unsold securities previously registered on the Company’s Statement F-3 (No. 333-239843) filed on July 13, 2020,   
 and declared effective on July 22, 2020 (the “Prior F-3 Registration Statement”) and carried forward to the Prior S-3 Registration Statement. The filing fees previously paid in connection with such unsold securities in the aggregate value  
 of $89,853,203.00 will continue to be applied to such unsold securities and the Company paid an additional fee of $1,553.47 in connection with the filing of this Registration Statement. This Registration Statement is being filed to replace 
 the Prior S-3 Registration Statement prior to its expiration.                                                                                                                                                                                   |

| ** | Estimated |

Item 15. Indemnification of Directors and Officers General. Our amended and restated articles of incorporation (the “Articles”) set forth the following provisions regarding the grant of insurance coverage, indemnification and an exemption from liability to any of our directors or officers, all subject to the provisions of applicable law. In accordance with such provisions and pursuant to the requisite corporate approvals, we have obtained liability insurance covering our directors and officers, have granted indemnification undertakings to our directors and officers and have agreed to exempt our directors and officers from liability in each case, to the fullest extent permitted by our Articles and applicable law, including with respect to liabilities resulting from this offering to